
Timing of surgery after neoadjuvant chemoradiotherapy affects oncologic outcomes in patients with esophageal cancer
Author(s) -
QiXin Shang,
YuShang Yang,
YiMin Gu,
Xiaoxi Zeng,
HanLu Zhang,
Weipeng Hu,
Wenping Wang,
Long-Qi Chen,
Yong Yuan
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i6.687
Subject(s) - medicine , esophageal cancer , hazard ratio , esophagectomy , confidence interval , chemoradiotherapy , subgroup analysis , oncology , adenocarcinoma , neoadjuvant therapy , cancer , surgery , breast cancer
The optimal time interval between neoadjuvant chemoradiotherapy (nCRT) and esophagectomy in esophageal cancer has not been defined.